Brachytherapy catheters Market

Brachytherapy catheters Market Overview

The brachytherapy catheters market is anticipated to register a CAGR of 6.5% during the forecast period, up from US$ 894.34 Mn in 2022 to reach a valuation of US$ 1678.79 Mn by 2032.

Attributes	Details
Brachytherapy Catheters Market Value (2022)	US$ 894.34 Mn
Brachytherapy Catheters Market Forecast Value (2032)	US$ 1678.79 Mn
Brachytherapy Catheters CAGR (2022-2032)	6.5%

The demand for brachytherapy catheters is on rise as they are used to treat cancer by inserting a small amount of radioactive material near malignant tissues and killing or slowing growth by delivering high to low doses of radiation to the cells.

The sales of brachytherapy catheters is anticipated to rise throughout the forecast period as they deliver highly localized radiation to malignant tissues, lowering the chance of delivering radiation to normal cells and preventing radiation-related diseases. These factors are anticipated to contribute to the growth of brachytherapy catheters market share.

Another factor augmenting the demand for brachytherapy catheters is their functionality and ease of use. Brachytherapy catheters are soft, hollow tubes that retain radioactive material near the target site (cancerous tissue) for a set period of time before being removed with the radiation source. The sales of brachytherapy catheters are rising as it is extremely effective. Brachytherapy catheters targets malignant tissue while leaving normal tissues alone.

Increasing cancer cases is anticipated to have a positive impact on the sales of brachytherapy catheters, as a result, the global brachytherapy catheters market share is likely witness growth.

According to the American Cancer Society, the number of new cancer cases worldwide is expected to reach 21.6 million by 2030, while cancer deaths are expected to exceed 13 million.

This significant increase in cancer cases can be linked to people all around the world adopting unhealthy lifestyles which further increases the demand for brachytherapy catheters. Another factor contributing to the sales of brachytherapy catheters is the spread of cancer among people is the use of tobacco, which accounts for more than 20% of cancer deaths worldwide each year, according to the same source.

High efficiency and a shorter treatment time period are two major factors propelling the demand for brachytherapy catheters, and it is also expected to boost brachytherapy catheters market share.

What are the Key Drivers to the Brachytherapy Catheters Market Share?

The demand for brachytherapy catheters is rising as they are used to deliver radioactive material directly into or near a tumor in order to treat cancer. In recent years, advancements in catheter and applicator technology have significantly improved treatment accuracy, performance, and effects in brachytherapy. The sales of brachytherapy catheters is also increased due to significant advancements and the introduction of new applicator and catheter technology.

With advancements in multi-leaf collimators and accelerator design for external beam therapy, new catheter-associated technology, as well as new assets and applicators, enhanced brachytherapy treatments are now possible. As a result of this, the sales of brachytherapy catheters is anticipated to rise drastically during the forecast period.

The technological advancements in brachytherapy are a critical component for the growth of the global brachytherapy catheters market size. Brachytherapy catheters have evolved significantly in all areas over the last few years, including patient selection, treatment planning, technique, and generation. This has propelled the rise in demand for brachytherapy catheters during the projected period.

With the advancement of remote after-loading systems and new radioactive assets, as well as advancements in three-D imaging modalities and computerised treatment planning systems, the sales of brachytherapy catheters rose significantly. These are some of the factors that are expected to drive the brachytherapy catheters market share.

The recent development of cutting-edge radiation treatment plans and imaging methods allows for more conformal radiation therapy. Such technological advancements are expected to drive the brachytherapy catheters market share upward during the forecast period.

Which Region holds the Highest Growth Potential in the Brachytherapy Catheters Market?

North America led the brachytherapy catheters market, followed by Europe, Asia Pacific, the Middle East, and Africa, in that order. The revenue growth of the brachytherapy catheters market in North America can be attributed to several factors, including improved healthcare infrastructure, the strong presence of leading vendors, end-user awareness of the clinical benefits of brachytherapy, and an increase in the region's cancer incidence.

The Asia-Pacific brachytherapy catheters market is expected to grow significantly due to the existence of emerging markets like as India and China, as well as growing medical tourism due to low prognosis prices and hospital upgrading in these countries. Furthermore, due to the vast population pool in the area, gadget manufacturers are investing heavily in emerging markets. Europe is predicted to be the second most profitable market for brachytherapy catheters.

How is the Competitive Landscape in the Brachytherapy Catheters Market?

Some of the key players in brachytherapy catheters market are Hologic, Elekta, TeamBest, Varian, BK Medical and others.

Recent Developments

• Eckert and Ziegler BEBIG GmbH has purchased WOLF-Medizintechnik GmbH, which makes X-ray systems for the treatment of skin tumours.
• In January 2018, HB and Alpha Tau Medical announced a collaboration to offer the world's first Alpha Radiation Brachytherapy to Japan.
• iCAD Receives CFDA Approval to Market Brachytherapy Device in China in August 2017.

Scope of Report

Report Attribute	Details
Growth rate	CAGR of 7% from 2022 to 2032
Base year for estimation	2021
Historical data	2015 - 2020
Forecast period	2022 - 2032
Quantitative units	Revenue in USD million and CAGR from 2022 to 2032
Report coverage	Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis,
Segments covered	Product type, application type, end user, region
Regional scope	North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand
Country scope	U.S.; Canada; Mexico; Germany; U.K.; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa
Key companies profiled	Hologic, Elekta, TeamBest, Varian, BK Medical
Customization scope	Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs.